Related Experiment Videos
[Surgical treatment of myasthenia gravis in children]
Insights
This study on pediatric myasthenia gravis in 33 children found that thymectomy and modern diagnostics yield favorable outcomes in 75% of cases. Surgical intervention improved patient adaptation and reduced reliance on anticholinesterase agents.
Area of Science:
- Pediatric Neurology
- Thoracic Surgery
- Immunology
Context:
- Myasthenia gravis (MG) is a rare autoimmune disorder affecting neuromuscular junctions.
- Pediatric MG presents unique diagnostic and therapeutic challenges.
- This study focuses on surgical management of MG in a pediatric cohort.
Purpose:
- To evaluate the efficacy of thymectomy in treating pediatric myasthenia gravis.
- To assess diagnostic accuracy using various clinical and pharmacological tests.
- To analyze long-term outcomes and patient adaptation post-surgery.
Summary:
- 33 children (3-15 years) with moderate to extremely severe MG underwent diagnosis via neostigmine methylsulfate, cold, and D-tubocurarine tests.
- Thymectomy via T-shaped sternotomy was performed in 32 patients, with thymogenic MG confirmed in 31.
- No fatal outcomes were reported; 75% of patients achieved favorable long-term results, assessed by adaptation, medication use, and electrodiagnostic tests.
Impact:
- Demonstrates the effectiveness of surgical intervention in pediatric MG.
- Highlights the importance of precise diagnostics for treatment planning.
- Provides evidence for favorable long-term prognosis with modern treatment approaches.
Abstract:
The article deals with the treatment of myasthenia in 33 children whose ages ranged from 3 to 15 years. Myasthenia of moderate severity was diagnosed in 14, severe in 15, and extremely severe in 2 children. To make a precise diagnosis, loading, neostigmine methylsulfate, cold, and D-tubocurarine tests were conducted. Thymectomy was performed in 32 patients. The operation was carried out through a T-shaped sternotomy approach. Thymogenic myasthenia was verified in 31 patients and thymomogenic only in one patient. There were no fatal outcomes. The late-term results were studied in 12 patients in follow-up periods of 3 to 6 years. Adaptational activity of the patients, anticholinesterase agents and the results of stimulant electric myography served as the criterion in appraising the late-term results. Modern diagnostic methods and surgical intervention ensure a favourable result in 75% of patients.